New International Consensus on CGM Clinical Trial Metrics Aims to Spur Diabetes Treatment Advances

SAN FRANCISCO, Dec. 6, 2022 /PRNewswire/ -- The diaTribe Foundation, Advanced Technologies & Treatments for Diabetes (ATTD), and the Time in Range Coalition announced today a new international consensus regarding continuous glucose monitoring (CGM) metrics for clinical trials to help...

Click to view original post